Related Experiment Videos

Hypothalamic-mediated model for Creutzfeldt-Jakob disease: relation to hemispheric chemical dominance

Rave Kumar Kurup1, Parameswara Achutha Kurup

  • 1Department of Neurology, Medical College Hospital, Trivandrum, Kerala, India.

Insights

Creutzfeldt-Jakob Disease (CJD) shows an upregulated isoprenoid pathway and increased digoxin synthesis, particularly with right hemispheric dominance. These metabolic changes in CJD patients highlight the pathway's role in disease pathogenesis.

Area of Science:

  • Biochemistry
  • Neuroscience
  • Metabolic pathways

Background:

  • The isoprenoid pathway is crucial for cellular functions.
  • Alterations in this pathway are implicated in various neurological disorders.
  • Creutzfeldt-Jakob Disease (CJD) is a fatal neurodegenerative prion disease.

Purpose of the Study:

  • To investigate the isoprenoid pathway, including endogenous digoxin synthesis, in Creutzfeldt-Jakob Disease (CJD).
  • To compare these metabolic changes with those in patients exhibiting right or left hemispheric chemical dominance.

Main Methods:

  • Assessment of the isoprenoid pathway and digoxin levels in CJD patients.
  • Comparative analysis in patients with diagnosed right and left hemispheric dominance.
  • Evaluation of tryptophan and tyrosine catabolites, dolichols, glycoconjugates, lysosomal stability, ubiquinone, free radicals, and membrane lipid composition.

Main Results:

  • Upregulated isoprenoid pathway and increased digoxin synthesis observed in CJD patients and those with right hemispheric dominance.
  • Patients with right hemispheric dominance showed increased tryptophan catabolites, elevated dolichol and glycoconjugate levels, reduced lysosomal stability, low ubiquinone, increased free radicals, and altered membrane lipid ratios.
  • Left hemispheric dominance presented with reversed metabolic patterns.

Conclusions:

  • The isoprenoid pathway is significantly altered in CJD, correlating with right hemispheric chemical dominance.
  • These findings suggest a potential role for the isoprenoid pathway in CJD pathogenesis.
  • Hemispheric chemical dominance may influence metabolic dysregulation in neurodegenerative conditions.

Related Concept Videos